Long-Term Data Shows Sustained Skin Clearance in Psoriasis with FDA-Approved Biologic
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed